多模式支持护理路径在消化道癌症患者中的可行性研究
Real-world feasibility of a nutritional frailty score-guided multimodal supportive care pathway in patients with digestive cancer
两项单中心研究评估了营养衰弱评分指导下的多模式支持护理路径在消化道癌症患者中的可行性。ParcoursDig 研究中,仅 44% 的患者完成了全程支持护理,未见生活质量或生存率显著改善。PrePOP 研究显示,基线营养不良患者化疗剂量减少,但早期营养干预可防止进一步恶化。研究建议高强度和个体化护理路径需在更大规模研究中进一步评估。
Abstract
Frailty, malnutrition, and sarcopenia are highly prevalent in digestive oncology and adversely affect treatment tolerance, toxicity, and survival. The integration of multimodal, multidisciplinary supportive care may mitigate these risks, but feasibility and clinical impact in routine practice remain uncertain. We conducted two complementary single-center studies at a French cancer center. We developed a Nutritional Frailty Score to assess the risk of nutritional deterioration in patients receiving first-line chemotherapy for digestive cancers. ParcoursDig (NCT04478175) prospectively assessed the feasibility of systematic multimodal supportive care (dietitian, physiotherapist, palliative care) using risk stratification based on this score in patients with localized or advanced digestive cancers. PrePOP was a retrospective observational study of patients with pancreatic or esophagogastric cancers receiving perioperative chemotherapy and surgery. Outcomes included treatment completion, nutritional changes, toxicities, surgical complications, and survival. In ParcoursDig, only 44% of patients completed the full supportive care pathway (63% in sensitivity analysis), falling short of the predefined feasibility threshold. No significant improvements were seen in health-related quality of life or survival, highlighting real-world implementation challenges. In PrePOP, baseline malnutrition prevalence was 71% (31% severe). Malnutrition was clinically associated with higher rates of chemotherapy dose reduction but not with surgical complications or survival. Weight loss during systemic therapy was common, but early nutritional intervention appeared to prevent further deterioration for some patients. Muscle mass loss during follow-up correlated with poorer prognosis, emphasizing the need for longitudinal, muscle-specific assessment. In this exploratory, single-centre experience, unsupervised, low-intensity interventions did not achieve the predefined feasibility threshold or measurable clinical benefit. Supervised, high-intensity modalities (e.g., structured interval training) and individualized care trajectories with longitudinal follow-up warrant evaluation in larger, multicentre studies.
Abbreviations
- APA:
-
Adapted physical activity
- BMI:
-
Body mass index
- eCRF:
-
Electronic case report form
- ESMO:
-
European Society of Medical Oncology
- ESPEN:
-
European Society of Parenteral and Enteral Nutrition
- GI:
-
Gastro-intestinal
- HAS:
-
French Health Authority (Haute Autorité de Santé)
- HIIT:
-
High intensity interval training
- HRQoL:
-
Health-related quality of life
- ITT:
-
Intention to treat
- m:
-
Meters
- MICT:
-
Moderate intensity continuous training
- mITT:
-
Modified intention to treat
- N:
-
Number
- ONS:
-
Oral nutritional supplements
- PDAC:
-
Pancreatic-ductal adenocarcinoma
- PS:
-
Performance status
- SFNCM:
-
French Society of Nutrition and Metabolism (Société Française de Nutrition Clinique et Métabolisme)
- TS:
-
Therapeutic sequence
- VAS:
-
Visual analog scale (of food intake)
- W:
-
Week
- WL:
-
Weight loss
Acknowledgements
Our sincere gratitude to the Gastrointestinal Medical Oncology and Supportive Care Team at the Curie Institute, and to the Surgical Team at Ambroise Paré Hospital, for their outstanding multidisciplinary collaboration and unwavering commitment to the comprehensive care of patients.
Author information
Authors and Affiliations
Institut Curie, 35, Rue Daily, Saint-Cloud, France
Eva Ester Molina Beltran, Lucie Gentilhomme, Aude Guillemin, Elisabeth Lucchi, Antoine Fleury, Agnès Moura, Sara Petit De Mirbeck, Betty Peignelin, Anaïs Violle, Caroline Mencarelli & Cindy Neuzillet
Laboratory Health Systemic Process-P2S, UR4129, Faculty of Medicine Laennec, University Claude Bernard Lyon 1, University of Lyon, 11 Rue Guillaume Paradin, 69008, Lyon, France
Eva Ester Molina Beltran, Claude Dussart & Florence Carrouel
Université Saint-Quentin en Yvelines, Guyancourt, France
Cindy Neuzillet
Unité de Méthodologie et de Qualité de Vie en Cancérologie (INSERM UMR 1098), CHU de Besançon, Besançon, France
Cyril Boisson
Hôpital Beaujon, Clichy, France
Anne-Laure Vedie
Hôpital Ambroise-Paré, Boulogne-Billancourt, France
Frédérique Peschaud & Renato Micelli-Lupinacci
INSERM, INRAE, CNAM, Center of Research in Epidemiology and Statistics (CRESS), Nutritional Epidemiology Research Team (EREN), Université Sorbonne Paris Nord and Université Paris Cité, Bobigny, France
Samuel Pereira
Institut Médico Educatif Toulouse-Lautrec, 131 Avenue de la Celle Saint-Cloud, 92420, Vaucresson, France
Yasmina Brouillet-Benkirane
Authors
- Eva Ester Molina Beltran
- Lucie Gentilhomme
- Anne-Laure Vedie
- Aude Guillemin
- Samuel Pereira
- Elisabeth Lucchi
- Antoine Fleury
- Agnès Moura
- Sara Petit De Mirbeck
- Betty Peignelin
- Anaïs Violle
- Caroline Mencarelli
- Yasmina Brouillet-Benkirane
- Frédérique Peschaud
- Renato Micelli-Lupinacci
- Claude Dussart
- Florence Carrouel
- Cyril Boisson
- Cindy Neuzillet
Corresponding author
Correspondence to Eva Ester Molina Beltran.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
ParcoursDig study has been approved by the Committee Ile-de-France VII the 17th of June 2020 (Supplementary File 2).
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Molina Beltran, E.E., Gentilhomme, L., Vedie, AL. et al. Real-world feasibility of a nutritional frailty score-guided multimodal supportive care pathway in patients with digestive cancer. Sci Rep (2026). https://doi.org/10.1038/s41598-026-72704-7
Received: 15 December 2025
Accepted: 17 September 2026
Published: 05 November 2026
DOI: https://doi.org/10.1038/s41598-026-72704-7
Keywords
来源:Nature 健康护理主题 · nature.com